$FENC SEC Filings

Filed On	Filing
19 Oct 2026	SCHEDULE 13G/A
13 Oct 2026	Form 4: Cioffi Christiana Marie, Chief Strategy Officer Received 3,946 shares as a grant or award ($21.8K)
13 Oct 2026	Form 4: Sayad Pierre Sargis, Chief Medical Officer Received 3,846 shares as a grant or award ($21.3K)
13 Oct 2026	Form 4: Evans Terry L, Chief Commercial Officer Received 2,326 shares as a grant or award ($12.9K)
13 Oct 2026	Form 4: Hackman Jeffrey S., Director Received 2,224 shares as a grant or award ($12.3K)
13 Oct 2026	Form 4: Andrade Robert, CHIEF FINANCIAL OFFICER Received 3,846 shares as a grant or award ($21.3K)
01 Oct 2026	Form 4: Cioffi Christiana Marie, Chief Strategy Officer Received 156 shares as a grant or award
01 Oct 2026	Form 4: Sayad Pierre Sargis, Chief Medical Officer Received 168 shares as a grant or award
01 Oct 2026	Form 4: Evans Terry L, Chief Commercial Officer Received 168 shares as a grant or award
01 Oct 2026	Form 4: Hackman Jeffrey S., Director Received 1,159 shares as a grant or award
01 Oct 2026	Form 4: Andrade Robert, CHIEF FINANCIAL OFFICER Received 1,703 shares as a grant or award
17 Sep 2026	8-K: Other Events Fennec Pharmaceuticals Announces ORAL PRESENTATION OF DETAILED Results From Investigator-Initiated Phase 2 STS-J01 Clinical Study of PEDMARK® in Japan AT SIOP 2026
16 Sep 2026	Form 4: Brughera Marco Maria, Director Received 15,545 shares by exercise or conversion ($32.8K) · Sold 15,545 shares ($160K)
15 Sep 2026	144
01 Sep 2026	144
01 Sep 2026	Form 4: Raykov Rosty, Former Director Received 2,778 shares as a grant or award · Sold 10,000 shares ($121K)
31 Aug 2026	Form 4: Sayad Pierre Sargis, Chief Medical Officer Received 168 shares as a grant or award · Sold 12,000 shares ($146K)
31 Aug 2026	Form 4: Evans Terry L, Chief Commercial Officer Received 168 shares as a grant or award
31 Aug 2026	Form 4: Cioffi Christiana Marie, Chief Strategy Officer Received 156 shares as a grant or award
31 Aug 2026	Form 4: Hackman Jeffrey S., Director Received 1,159 shares as a grant or award

Comments